[Immunocytochemistry in malignant serous effusions]

Eric Piaton1, Serge Vancina, Michèle Cottier

  • 1Service d'Anatomie et Cytologie Pathologiques, Hôpital Edouard Herriot, 3 place d'Arsonval, 69437 Lyon Cedex 03. eric.piaton@chu-lyon.fr

Annales De Pathologie
|January 27, 2007
PubMed

Insights

Immunocytochemistry aids in classifying malignant serous effusions. Using a panel of antibodies with mesothelial cell markers improves diagnostic accuracy for pathologists.

Area of Science:

  • Cytopathology
  • Oncology
  • Immunohistochemistry

Context:

  • Malignant serous effusions present diagnostic challenges.
  • Accurate classification is crucial for patient management and treatment decisions.

Purpose:

  • To evaluate the utility of immunocytochemistry in diagnosing malignant serous effusions.
  • To recommend optimal methodologies and antibody panels for improved accuracy.

Summary:

  • Immunocytochemistry is a valuable tool for typing malignant serous effusions.
  • Various preparation methods exist, including smearing, cytocentrifugation, cell blocks, and liquid-based cytology.
  • A recommended approach involves using a panel of antibodies that combines carcinoma markers with mesothelial cell markers.
  • The effectiveness of immunocytochemistry is influenced by the pathologist's experience.

Impact:

  • Enhanced diagnostic accuracy for malignant serous effusions.
  • Improved patient stratification and treatment planning.
  • Potential for wider adoption of immunocytochemistry in routine diagnostics.